GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Emyria EMD.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.04

-5.26%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$3.9m

FY2018FY2026

Net income

−A$6.1m

FY2018FY2026

Free cash flow

−A$4.9m

FY2018FY2026

Shareholders' equity

A$8.8m

FY2018FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueA$3.9mA$1.4mA$2.2mA$1.6mA$1.8mA$2.0mA$1.0mA$109,909—
Research and developmentA$531,130A$812,229A$2.1mA$1.8mA$2.2mA$2.6mA$1.5mA$221,487A$221,487
Operating income−A$6.3m−A$2.6m−A$6.9m−A$7.1m−A$8.5m−A$5.7m−A$5.6m−A$2.7m−A$64,320
Net income−A$6.1m−A$3.1m−A$11.5m−A$5.1m−A$7.3m−A$4.9m−A$5.2m−A$2.7m−A$64,339
Diluted earnings per share-0.01-0.00-0.03-0.02-0.03-0.02-0.03-0.01-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsA$11.5mA$6.6mA$5.4mA$10.2mA$8.2mA$9.1mA$5.1mA$3.5mA$3.1m
Cash and short-term investmentsA$7.3mA$3.6mA$1.6mA$2.7mA$3.9mA$6.5mA$3.7mA$2.6mA$3.0m
Total liabilitiesA$2.6mA$1.3mA$3.0mA$3.4mA$1.9mA$1.9mA$1.3mA$3.0mA$250,429
DebtA$787,384A$613,499A$1.7mA$1.3mA$632,707A$949,700A$610,815A$3.2m—
Shareholders' equityA$8.8mA$5.3mA$2.4mA$6.8mA$6.3mA$7.2mA$3.8mA$499,539A$2.8m
Shares outstanding807m679m421m333m280m260m209m195m131m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−A$4.6m−A$2.7m−A$4.3m−A$3.8m−A$5.4m−A$3.9m−A$4.5m−A$2.6m−A$20,816
Capital spending−A$366,159−A$13,888−A$159,097−A$3.2m−A$2.0m−A$661,386−A$201,806−A$844,800−A$844,800
Free cash flow−A$4.9m−A$2.7m−A$4.4m−A$7.0m−A$7.5m−A$4.6m−A$4.7m−A$3.4m−A$865,616
Dividends paid———−A$62,616−A$767,725−A$341,833−A$527,355——

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueA$2.4mA$1.4mA$736,548A$658,199A$1.1mA$1.1mA$860,318A$430,159
Operating income−A$3.8m−A$2.5m−A$1.5m−A$1.1m−A$1.7m−A$3.7m−A$3.1m−A$300,724
Net income−A$3.7m−A$2.4m−A$2.2m−A$968,997−A$661,975−A$10.8m−A$1.2m−A$579,424
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.03-0.00-0.00
Cash from operations−A$2.0m−A$2.0m−A$1.0m−A$1.0m—−A$4.0m——
Capital spending——————−A$1.0m—
Total assetsA$11.5mA$13.7mA$6.6mA$5.0mA$5.4mA$6.2mA$10.2mA$10.2m
Cash and short-term investmentsA$7.3mA$10.5mA$3.6mA$1.6mA$1.6mA$2.0mA$2.7mA$2.7m
DebtA$126,771A$556,944A$613,498A$802,690A$1.7mA$3.0mA$1.3m—
Shareholders' equityA$8.8mA$12.1mA$5.3mA$3.4mA$2.4mA$950,030A$6.8mA$4.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue34.6%14.4%—
Operating income-4.2%1.9%—
Net income6.0%4.5%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-5.0-12.7-1.3-3.4-6.5-20.3-3.6
Price to sales7.928.76.510.926.050.318.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.